A story of innovation, passion and medical value continues
- haemoview
- Aug 4
- 1 min read
It has been a privilege and a pleasure to support nearly all of Andreas’s innovations over the past 15 years. The journey from the early days of innovation to today's MultiClot system is not only a testament to technological excellence but also to the persistence of a vision rooted in clinical relevance and collaboration.
This new platform represents more than just technical progress—it reflects the collective wisdom of decades of development, multidisciplinary input, and frontline clinical experience. We’re proud to have played a part in that journey and look forward to what lies ahead.
The future is bright, and we're excited to continue doing what we do best—advancing patient care through innovation.
To read Andreas's post, see here
A story of innovation, passion and medical value continues
Almost 30 years ago we filed for the patent for the ROTEG (later ROTEM©) analyzer at the US patent office (US5777215A). https://lnkd.in/duKSrtp9
It is great to see now another great instrument platform to prepare for market entry. The MultiClot system is the summary of the inputs and hard work of a multinational team, and many clinical users and experts that have supported us over the years.
A very special thanks goes to the Semmelweis University, Budapest, for all the inspiration and cooperation!
Our vision is that the MultiClot will become a standard method for viscoelastometry due to its best-in-class test menu (including tests for DOACs and antifibrinolytics) and its superior economics. This combination will be highly attractive for state of the art maximum care centers, but also for clinical centers in countries with lower healthcare spending.
To see what's coming, please visit the Apiro website https://www.apiro.eu/our-platform
